A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
Part of paid clinical trials in Encinitas, California.
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Study ID
- NCT07140939
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Subcutaneous Fat
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- CBL-514 Injection — DRUGProvided as a ready for use injectable CBL-514 solution
- 0.9% Sodium Chloride — OTHERInjectable 0.9% Sodium Chloride solution as placebo
Study Details
A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Key Dates
- First listed
- Aug 26, 2025
- Start date
- Sep 1, 2026
- Status verified
- Sep 2026
- Primary completion
- Jul 31, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 320 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: CBL-514 injectionParticipants will receive CBL-514 administrated up to 120 mL (with 50 injections) per treatment at a 4-weeks interval for up to 4 treatments.
- Placebo Comparator: Injectable 0.9% Sodium Chloride solutionParticipants will receive 0.9% Sodium Chloride administrated up to 120 mL (with 50 injections) per treatment at a 4-week interval for up to 4 treatments.
Primary Outcome Measure
Percentage of participants with at least a 2-grade improvement on Patient Reported Abdominal Fat Rating Scale (PR-AFRS) and Clinician Reported Abdominal Fat Rating Scale (CR-AFRS) in the CBL-514 group versus the placebo group. [ Time Frame: From baseline to 4 weeks after final treatment ]
Central Contacts
- Candra Chou+886-2-26971355
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Investigational site 1 | Encinitas | California | 92024 | - |
| Investigational site 2 | West Palm Beach | Florida | 33401 | - |
| Investigational site 3 | Chicago | Illinois | 60610 | - |
| Investigational site 4 | Baton Rouge | Louisiana | 70809 | - |
| Investigational site 5 | Hunt Valley | Maryland | 21030 | - |
| Investigational site 6 | Omaha | Nebraska | 68144 | - |
| Investigational site 7 | Hackensack | New Jersey | 07601 | - |
| Investigational site 8 | New York | New York | 10028 | - |
| Investigational site 9 | Charlotte | North Carolina | 28207 | - |
| Investigational site 10 | Nashville | Tennessee | 37215 | - |
| Investigational site 11 | Pflugerville | Texas | 78660 | - |
Find similar trials in Encinitas, CA
Related Studies
- A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )PHASE3 · Not Yet Recruiting · Caliway Biopharmaceuticals Co., Ltd. · Encinitas, California
- A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)PHASE3 · Not Yet Recruiting · Caliway Biopharmaceuticals Co., Ltd. · Encinitas, California